These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 19689402

  • 1. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R.
    Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
    [Abstract] [Full Text] [Related]

  • 2. Zoledronic acid for Paget's disease of bone.
    Maricic M.
    Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
    [Abstract] [Full Text] [Related]

  • 3. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 4. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM, Scott LJ.
    Drugs; 2007 Mar; 67(5):793-804. PubMed ID: 17385948
    [Abstract] [Full Text] [Related]

  • 5. The use of zoledronic acid for Paget's disease of bone.
    Maricic M.
    Curr Osteoporos Rep; 2006 Mar; 4(1):40-4. PubMed ID: 16527007
    [Abstract] [Full Text] [Related]

  • 6. Zoledronic acid for treatment of Paget's disease of bone.
    Devogelaer JP, Manicourt DH.
    Expert Opin Pharmacother; 2007 Nov; 8(16):2863-9. PubMed ID: 17956205
    [Abstract] [Full Text] [Related]

  • 7. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM.
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
    [No Abstract] [Full Text] [Related]

  • 8. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
    Conesa Mateos A, Rotés Sala D, Almirall Bernabé M, Carbonell Abelló J.
    Med Clin (Barc); 2006 Oct 28; 127(16):635-6. PubMed ID: 17145033
    [No Abstract] [Full Text] [Related]

  • 9. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F.
    Clin Exp Rheumatol; 2007 Oct 28; 25(3):464-6. PubMed ID: 17631747
    [Abstract] [Full Text] [Related]

  • 10. Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget's disease.
    Watts MR, Ellims AH, Eccleston DS.
    Med J Aust; 2014 Feb 17; 200(3):150. PubMed ID: 24528425
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of Paget's disease of bone: importance of the zoledronic acid].
    Griz L, Colares V, Bandeira F.
    Arq Bras Endocrinol Metabol; 2006 Oct 17; 50(5):845-51. PubMed ID: 17160207
    [Abstract] [Full Text] [Related]

  • 12. [Effect of a single dose of zoledronic acid in a case of Paget bone disease].
    Saban M, Fidalgo S, Díaz CA, Lutfi RJ.
    Medicina (B Aires); 2010 Oct 17; 70(5):445-8. PubMed ID: 20920964
    [Abstract] [Full Text] [Related]

  • 13. Current treatment approaches for Paget's Disease of Bone.
    Brandi ML.
    Discov Med; 2010 Sep 17; 10(52):209-12. PubMed ID: 20875342
    [Abstract] [Full Text] [Related]

  • 14. Management of patients with Paget's disease: a consensus document of the Belgian Bone Club.
    Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, Goemaere S, Kaufman JM, Reginster JY, Rozenberg S, Boonen S, Belgian Bone Club.
    Osteoporos Int; 2008 Aug 17; 19(8):1109-17. PubMed ID: 18504638
    [Abstract] [Full Text] [Related]

  • 15. Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
    Polyzos SA.
    Clin Rheumatol; 2011 Jan 17; 30(1):149-50. PubMed ID: 21053036
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ, Sternon J.
    Rev Med Brux; 2005 Jan 17; 26(6):513-7. PubMed ID: 16454155
    [Abstract] [Full Text] [Related]

  • 17. Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy.
    Pane A.
    Arch Ophthalmol; 2007 Oct 17; 125(10):1440-1. PubMed ID: 17923566
    [No Abstract] [Full Text] [Related]

  • 18. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
    Grados D, Martínez-Morillo M, Holgado S, Erra A.
    Med Clin (Barc); 2014 May 20; 142(10):469-70. PubMed ID: 24120108
    [No Abstract] [Full Text] [Related]

  • 19. Therapy with zoledronic acid, 5 mg, for a patient with Paget disease of bone.
    Tucci JR.
    Endocr Pract; 2008 May 20; 14(5):607-10. PubMed ID: 18753106
    [Abstract] [Full Text] [Related]

  • 20. Zoledronic acid: a review of its use in breast cancer.
    Lyseng-Williamson KA.
    Drugs; 2008 May 20; 68(18):2661-82. PubMed ID: 19093706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.